Home > Insider Trading > Filing (0001209191-14-008251)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1429560	Trevena Inc	TRVN	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1198321	Farah Champsi	C/O Alta Partners, One Embarcadero Center, 37Th Floor San Francisco CA 94111	Yes	No	Yes	No
1198325	Daniel Janney	C/O Alta Partners, One Embarcadero Center, 37Th Floor San Francisco CA 94111	No	No	Yes	No
1198330	P Guy Nohra	C/O Alta Partners, One Embarcadero Center, 37Th Floor San Francisco CA 94111	No	No	Yes	No
1399763	Alta Partners Viii, L.p.	C/O Alta Partners, One Embarcadero Center, 37Th Floor San Francisco CA 94111	No	No	Yes	No
1399894	Alta Partners Management Viii, Llc	C/O Alta Partners, One Embarcadero Center, 37Th Floor San Francisco CA 94111	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-02-05	967,741	$0.00	967,741	No	4	C	Indirect	Direct and Indirect - See Footnote
Common Stock	Acquisiton	2014-02-05	1,354,838	$0.00	2,322,579	No	4	C	Indirect	Direct and Indirect - See Footnote
Common Stock	Acquisiton	2014-02-05	314,516	$0.00	2,637,095	No	4	C	Indirect	Direct and Indirect - See Footnote
Common Stock	Acquisiton	2014-02-05	780,757	$0.00	3,417,852	No	4	C	Indirect	Direct and Indirect - See Footnote
Common Stock	Acquisiton	2014-02-05	472,410	$7.00	3,890,262	No	4	P	Indirect	Direct and Indirect - See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	Direct and Indirect - See Footnote
No	4	C	Indirect	Direct and Indirect - See Footnote
No	4	C	Indirect	Direct and Indirect - See Footnote
No	4	C	Indirect	Direct and Indirect - See Footnote
No	4	P	Indirect	Direct and Indirect - See Footnote

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Preferred Stock	Disposition	2014-02-05	6,000,000	$0.00	967,741	$0.00
Common Stock	Series B Preferred Stock	Disposition	2014-02-05	8,400,000	$0.00	1,354,838	$0.00
Common Stock	Series B-1 Preferred Stock	Disposition	2014-02-05	1,950,000	$0.00	314,516	$0.00
Common Stock	Series C Preferred Stock	Disposition	2014-02-05	4,840,686	$0.00	780,757	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect

Footnotes

Each share of convertible preferred stock was convertible at any time, at the holder's election, into the issuer's common stock on a 6.2 to 1 basis. Effective immediately prior to the closing of the issuer's initial public offering of its common stock, each share of convertible preferred stock automatically converted on a 6.2 to 1 basis into shares of common stock of the issuer. The convertible preferred stock had no expiration date.
The securities are held of record by Alta Partners VIII, L.P. ("APVIII"). Alta Partners Management VIII, LLC ("APMVIII") is the general partner of APVIII. Guy Nohra, Daniel Janney and Farah Champsi are managing directors of APMVIII and exercise shared voting and investment power with respect to the shares onwed by APVIII. Each of the reporting persons disclaims beneficial ownership of such securities, except to the extent of his, her or its proportionate pecuniary interest therein. Ms. Champsi is also a director of the issuer.
Includes two shares of common stock issued to the reporting persons in connection with the aggregation of fractional shares.
These shares were purchased by APVIII.